Danimer Scientific (DNMR) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
Welcome extended to all participants, with the meeting webcast live following an earlier adjournment.
Agenda included election of directors, ratification of auditors, amendment of corporate charter, and increase of shares for equity incentives.
Board recommended voting in favor of all proposals to support long-term capital management and executive retention.
Board and executive committee updates
Introduction of directors and key executives present, including CFO, Chief Legal Officer, and representatives from the registrar and KPMG.
Shareholder proposals
Four proposals: elect 11 directors, ratify KPMG as auditor, amend charter to increase authorized shares to 600 million, and increase shares for the 2020 Long-Term Incentive Plan.
Motions and seconds for each proposal were made by stockholders and board members.
Latest events from Danimer Scientific
- PHA revenues to more than triple by mid-2025 as cost controls and financing support growth.DNMR
Q2 20242 Feb 2026 - Board authorized to enact a reverse stock split to maintain NYSE listing, pending board discretion.DNMR
EGM 202419 Jan 2026 - Q3 2024 saw lower sales and ongoing losses, with severe liquidity and debt concerns.DNMR
Q3 202413 Jan 2026